PHOENIX--(BUSINESS WIRE)--Zila, Inc.’s (Nasdaq GM: ZILA), Chairman, Chief Executive Officer, and President, Douglas D. Burkett, Ph.D., and Zila Pharmaceuticals Inc.’s President, Frank Bellizzi, D.M.D. each purchased approximately $50,000 of Zila common stock in the open market on December 18th.
